IP Verse

Compositions Comprising A Delivery Agent And Preparation Thereof

Patent No. EP2827845 (titled "Compositions Comprising A Delivery Agent And Preparation Thereof") was filed by Novo Nordisk on Mar 15, 2013. The application was issued on Dec 26, 2018.

Patent Summary

Pharmaceutical composition for treating diabetes and obesity that uses a specific mixing process to prevent over-lubrication issues. The composition contains granules made by mixing a delivery agent like N-(8-(2-hydroxybenzoyl)amino)caprylic acid with a lubricant like magnesium stearate for more than 5 minutes before dry granulation. This extended mixing time prevents negative effects on tablet properties when using high lubricant concentrations. The composition can be in the form of tablets or capsules.

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CMS CAMERON MCKENNA NABARRO OLSWANGSep 26, 2019-
GALENICUM HEALTH SLUSep 26, 2019GALENICUM HEALTH SLU
GENERICS UKSep 26, 2019TER MEER STEINMEISTER & PARTNER
HEXALSep 26, 2019MAIWALD
TEVA PHARMACEUTICALSSep 24, 2019VON KAUFFMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2827845

NOVO NORDISK
Application Number
EP13709232A
Filing Date
Mar 15, 2013
Status
Revoked
Oct 3, 2024
Publication Date
Dec 26, 2018
External Links
Slate, Register , Google Patents